Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Monday Links

Posted on September 18, 2023September 18, 2023 by John C. Goodman
  • GAO: unemployment insurance fraud during the pandemic as high as $135 billion. (That is roughly $1,350 for every household in America.)
  • Medicare targets cheap, generic, life saving drug for price “negotiation.”  (WSJ)
  • Rich countries get quality medicines; the poor sometimes get poison. But, contra NYT, the solution is markets, not regulation.
  • Court tells the FDA to stop playing doctor. (WSJ)
  • As a percent of income, lower-income people cheat more on their income taxes than higher income people. HT: David Henderson
  • Did the  eradication of hookworms cause modern allergies?
+

Saturday Links

Posted on September 16, 2023September 16, 2023 by John C. Goodman
  • Did the Social Sciences Research Network (SSRN) censor a meta study showing that lock downs had no effect on covid?
  • A smart pill — the size of a blueberry! — can be used to automatically detect key biological molecules in the gut that suggest problems, and wirelessly transmit the information in real time.
  • Robin Hansen: World population will peak in about thirty years, and then will likely fall by half every generation or two.
  • How the government sets Medicare prices: it’s “a pattern of combining dated, imprecise cost reports with idiosyncratic and opaque adjustments that were not constructed to guarantee the best outcomes for the dollars spent.”
+

Jindal & Katebi: Better Ways to Lower Drug Costs

Posted on September 15, 2023 by Devon Herrick

Former Louisiana governor (also former HHS secretary) Bobby Jindal and Charlie Katebi wrote an editorial in the Washington Examiner explaining how to rein-in high drug costs. To start with they don’t like the Inflation Reduction Act (IRA). President Biden championed the IRA as a way for Medicare to lower drug costs for a small, insignificant number of hyper expensive drugs. For the uninitiated, the IRA allows Medicare to identify 10 high-cost drugs and negotiate the cost down, using punitive excise taxes if drug companies refuse. Jindal and Katebi have a point. The IRAs price negotiation formula is a Rube Goldberg-type of policy mechanism that only Democrats’ legislative writers would think up.

+

Thursday Links

Posted on September 14, 2023September 14, 2023 by John C. Goodman
  • CIA whistle blower: the agency bribed analysts to cover up the covid lab leak.
  • Do you know the difference between “bagging” vs “buy and bill”? You may be spending too much for prescription drugs if you don’t.
  • Panel: Sudafed doesn’t work. I happen to know it does.
  • Opioid penetration map – county by county data. (WP)
  • Why did the Surgeon General’s report on loneliness ignore the pen pal remedy?
  • A new Human Rights Watch report: “Children in the US can be legally married in 41 states, physically punished by school administrators in 47 states, sentenced to life without parole in 22 states, and work in hazardous agriculture conditions in all 50 states.”
  • Generic drugs save consumers $338 billion every year.
+
  • Previous
  • 1
  • …
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • …
  • 259
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 45 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom